Connective tissue growth factor mediates transforming growth factor b-induced collagen synthesis : down-regulation by cAMP
暂无分享,去创建一个
Gary R. Grotendorst | K. Frazier | M. Duncan | M R Duncan | K S Frazier | S Abramson | S Williams | H Klapper | X Huang | G R Grotendorst | S. Williams | S. Abramson | H. Klapper | X. Huang | Shawn Williams | H. Klapper | Xinfa Huang | S. Abramson
[1] Gary R. Grotendorst,et al. Inhibition of TGF‐β‐stimulated CTGF gene expression and anchorage‐independent growth by cAMP identifies a CTGF‐dependent restriction point in the cell cycle , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] Gary R. Grotendorst,et al. Connective tissue growth factor: a novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? , 1998, The international journal of biochemistry & cell biology.
[3] J. Lasky,et al. Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis. , 1998, American journal of physiology. Lung cellular and molecular physiology.
[4] A. Roberts,et al. Smad-dependent Transcriptional Activation of Human Type VII Collagen Gene (COL7A1) Promoter by Transforming Growth Factor-β* , 1998, The Journal of Biological Chemistry.
[5] R. Bende,et al. Expression of connective tissue growth factor in human renal fibrosis. , 1998, Kidney international.
[6] Gary R. Grotendorst. Connective tissue growth factor: a mediator of TGF-β action on fibroblasts , 1997 .
[7] A. Mallat,et al. Pentoxifylline inhibits growth and collagen synthesis of cultured human hepatic myofibroblast‐like cells , 1997, Hepatology.
[8] W. März,et al. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. , 1997, Circulation.
[9] Gary R. Grotendorst,et al. Transforming growth factor beta induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[10] Gary R. Grotendorst,et al. Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors. , 1997, The international journal of biochemistry & cell biology.
[11] Gary R. Grotendorst,et al. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. , 1996, The Journal of investigative dermatology.
[12] Gary R. Grotendorst,et al. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[13] Gary R. Grotendorst,et al. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. , 1996, The Journal of investigative dermatology.
[14] T. C. Peterson,et al. Effect of pentoxifylline in rat and swine models of hepatic fibrosis: role of fibroproliferation in its mechanism. , 1996, Immunopharmacology.
[15] Gary R. Grotendorst,et al. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. , 1995, The Journal of investigative dermatology.
[16] B. Berman,et al. Pentoxifylline, pentifylline, and interferons decrease type I and III procollagen mRNA levels in dermal fibroblasts: evidence for mediation by nuclear factor 1 down-regulation. , 1995, The Journal of investigative dermatology.
[17] W. Border,et al. Transforming Growth Factor β in Tissue Fibrosis , 1994 .
[18] R. Clark. Basics of cutaneous wound repair. , 1993, The Journal of dermatologic surgery and oncology.
[19] Gary R. Grotendorst,et al. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. , 1993, Molecular biology of the cell.
[20] P. Bornstein,et al. Regulation of expression of the type I collagen genes. , 1993, American journal of medical genetics.
[21] M. Nilsen-Hamilton,et al. Opposite and independent actions of cyclic AMP and transforming growth factor beta in the regulation of type 1 plasminogen activator inhibitor expression. , 1992, The Biochemical journal.
[22] B. Berman,et al. Pentoxifylline inhibits certain constitutive and tumor necrosis factor-alpha-induced activities of human normal dermal fibroblasts. , 1992, The Journal of investigative dermatology.
[23] E. Linney,et al. Transgenic indicator mice for studying activated retinoic acid receptors during development. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[24] N. Lycke,et al. Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization. , 1992, Immunology.
[25] D. Foreman,et al. Control of scarring in adult wounds by neutralising antibody to transforming growth factor β , 1992, The Lancet.
[26] Gary R. Grotendorst,et al. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10 , 1991, The Journal of cell biology.
[27] K. Lapis,et al. Immunohistochemical detection of transforming growth factor‐β1 in fibrotic liver diseases , 1991, Hepatology.
[28] D. Brenner,et al. Transcription factors nuclear factor I and Sp1 interact with the murine collagen alpha 1 (I) promoter , 1991, Molecular and cellular biology.
[29] S. Jimenez,et al. Evaluation of transforming growth factor beta and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization. , 1990, The Journal of investigative dermatology.
[30] E. Leroy,et al. A possible role for transforming growth factor-beta in systemic sclerosis. , 1990, The Journal of investigative dermatology.
[31] A. Rizzino,et al. Inhibitory effects of transforming growth factor-beta on laminin production and growth exhibited by endoderm-like cells derived from embryonal carcinoma cells. , 1989, Differentiation; research in biological diversity.
[32] K. Hruska,et al. Second messenger signaling in the regulation of collagenase production by osteogenic sarcoma cells. , 1989, Endocrinology.
[33] B. Berman,et al. Differential regulation of collagen, glycosaminoglycan, fibronectin, and collagenase activity production in cultured human adult dermal fibroblasts by interleukin 1-alpha and beta and tumor necrosis factor-alpha and beta. , 1989, The Journal of investigative dermatology.
[34] B. Berman,et al. Pentoxifylline inhibits normal human dermal fibroblast in vitro proliferation, collagen, glycosaminoglycan, and fibronectin production, and increases collagenase activity. , 1989, The Journal of investigative dermatology.
[35] M. Sporn,et al. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β , 1988, Cell.
[36] P. Bornstein,et al. Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[37] M. Sporn,et al. Transforming growth factor beta. , 1988, Advances in cancer research.
[38] J. Rosenbloom,et al. PGE2 causes a coordinate decrease in the steady state levels of fibronectin and types I and III procollagen mRNAs in normal human dermal fibroblasts. , 1987, Biochemical and biophysical research communications.
[39] L. Williams,et al. Agents that increase cAMP accumulation block endothelial c-sis induction by thrombin and transforming growth factor-beta. , 1987, The Journal of biological chemistry.
[40] J. Heath,et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. , 1987, The EMBO journal.
[41] H. Moses,et al. Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. , 1987, The Journal of clinical investigation.
[42] M. Sporn,et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[43] H. Moses,et al. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[44] J. Massagué,et al. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.
[45] Gary R. Grotendorst,et al. Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. , 1985, The Journal of clinical investigation.
[46] M. Sporn,et al. Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo. , 1983, Science.
[47] W. Harvey,et al. A quantitative assay for collagen synthesis in microwell fibroblast cultures. , 1979, Analytical biochemistry.
[48] G. Todaro,et al. Growth factors from murine sarcoma virus-transformed cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[49] G. Todaro,et al. Epithelioid and fibroblastic rat kidney cell clones: Epidermal growth factor (EGF) receptors and the effect of mouse sarcoma virus transformation , 1978, Journal of cellular physiology.
[50] T. K. Hunt,et al. Respiratory gas tensions and pH in healing wounds. , 1967, American journal of surgery.
[51] J. Schilling,et al. Wound healing: a comparative study of the histochemical changes in granulation tissue contained in stainless steel wire mesh and polyvinyl sponge cylinders. , 1959, Surgery.